State Of Wisconsin Investment Board Arcus Biosciences, Inc. Transaction History

State Of Wisconsin Investment Board

  • $36.9 Billion
  • Q4 2024

A detailed history of State Of Wisconsin Investment Board transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 46,810 shares of RCUS stock, worth $418,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,810
Previous 29,849 56.82%
Holding current value
$418,481
Previous $456,000 52.85%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$14.28 - $18.44 $242,203 - $312,760
16,961 Added 56.82%
46,810 $697,000
Q2 2024

Aug 14, 2024
SELL
$14.59 - $18.48 $23,285 - $29,494
-1,596 Reduced 5.08%
29,849 $454,000
Q1 2024

May 14, 2024
SELL
$14.83 - $20.18 $60,091 - $81,769
-4,052 Reduced 11.42%
31,445 $593,000
Q4 2023

Feb 12, 2024
SELL
$13.43 - $19.63 $112,086 - $163,831
-8,346 Reduced 19.04%
35,497 $677,000
Q3 2023

Nov 14, 2023
BUY
$17.62 - $23.54 $120,467 - $160,942
6,837 Added 18.48%
43,843 $786,000
Q2 2023

Aug 14, 2023
SELL
$16.97 - $22.03 $34,160 - $44,346
-2,013 Reduced 5.16%
37,006 $751,000
Q1 2023

May 15, 2023
SELL
$15.96 - $23.15 $69,888 - $101,373
-4,379 Reduced 10.09%
39,019 $711,000
Q4 2022

Feb 14, 2023
SELL
$19.7 - $35.71 $6,540 - $11,855
-332 Reduced 0.76%
43,398 $897,000
Q3 2022

Nov 14, 2022
BUY
$23.23 - $30.07 $31,244 - $40,444
1,345 Added 3.17%
43,730 $1.14 Million
Q2 2022

Aug 15, 2022
SELL
$17.23 - $37.73 $246,647 - $540,104
-14,315 Reduced 25.25%
42,385 $1.07 Million
Q1 2022

May 13, 2022
SELL
$28.92 - $41.83 $231,360 - $334,640
-8,000 Reduced 12.36%
56,700 $1.79 Million
Q4 2021

Feb 11, 2022
BUY
$31.38 - $48.47 $251,040 - $387,760
8,000 Added 14.11%
64,700 $2.62 Million
Q2 2021

Aug 12, 2021
SELL
$22.75 - $35.77 $259,350 - $407,778
-11,400 Reduced 16.74%
56,700 $1.56 Million
Q1 2021

May 17, 2021
SELL
$26.16 - $41.39 $4.64 Million - $7.33 Million
-177,200 Reduced 72.24%
68,100 $1.91 Million
Q4 2020

Feb 03, 2021
SELL
$17.0 - $32.36 $49,300 - $93,844
-2,900 Reduced 1.17%
245,300 $6.37 Million
Q3 2020

Nov 16, 2020
BUY
$17.14 - $25.47 $3.33 Million - $4.95 Million
194,500 Added 362.2%
248,200 $4.25 Million
Q2 2020

Aug 12, 2020
BUY
$13.97 - $36.56 $50,292 - $131,616
3,600 Added 7.19%
53,700 $1.33 Million
Q1 2020

May 06, 2020
BUY
$8.78 - $19.28 $24,584 - $53,984
2,800 Added 5.92%
50,100 $695,000
Q3 2019

Nov 12, 2019
BUY
$6.44 - $10.18 $25,760 - $40,720
4,000 Added 9.24%
47,300 $430,000
Q2 2019

Aug 14, 2019
BUY
$7.29 - $13.38 $7,290 - $13,380
1,000 Added 2.36%
43,300 $344,000
Q1 2019

May 13, 2019
BUY
$8.95 - $12.49 $378,584 - $528,327
42,300 New
42,300 $528,000

Others Institutions Holding RCUS

# of Institutions
201
Shares Held
51.2M
Call Options Held
288K
Put Options Held
138K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $645M
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email